Carregant...
Directly Acting Antivirals for COVID-19: Where Do We Stand?
The outbreak of a novel coronavirus (SARS-CoV-2) in Wuhan, China in December 2019 has now become a pandemic with no approved therapeutic agent. At the moment, the genomic structure, characteristics, and pathogenic mechanisms of SARS-CoV-2 have been reported. Based upon this information, several drug...
Guardat en:
| Publicat a: | Front Microbiol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7419656/ https://ncbi.nlm.nih.gov/pubmed/32849448 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2020.01857 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|